137 related articles for article (PubMed ID: 2118750)
1. OKT 3: nursing considerations for use in acute renal transplant rejection.
Trusler LA
ANNA J; 1990 Aug; 17(4):299-303. PubMed ID: 2118750
[TBL] [Abstract][Full Text] [Related]
2. Nursing care of patients receiving orthoclone OKT 3.
Moir EJ
ANNA J; 1989 Aug; 16(5):327-8, 366. PubMed ID: 2505696
[TBL] [Abstract][Full Text] [Related]
3. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
4. Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients.
Palmer J; Slook P
ANNA J; 1992 Aug; 19(4):375-7. PubMed ID: 1520028
[TBL] [Abstract][Full Text] [Related]
5. [OKT 3 treatment of kidney transplant recipients].
Zlabinger GJ; Ulrich W; Pohanka E; Kovarik J
Wien Klin Wochenschr; 1990 Mar; 102(5):142-7. PubMed ID: 2108521
[TBL] [Abstract][Full Text] [Related]
6. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
Tvedegaard E; Olgaard K
Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
[No Abstract] [Full Text] [Related]
7. [Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)].
Ladefoged SD; Friedberg M; Glenthøj A
Ugeskr Laeger; 1988 Nov; 150(48):2974-6. PubMed ID: 3144080
[No Abstract] [Full Text] [Related]
8. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
[No Abstract] [Full Text] [Related]
9. Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection.
Georgitis JW; Browning MC; Steiner D; Lorentz WB
Ann Allergy; 1991 Apr; 66(4):343-7. PubMed ID: 1901692
[TBL] [Abstract][Full Text] [Related]
10. Nursing implications of immunosuppression in transplantation.
Shaefer M; Williams L
Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575
[TBL] [Abstract][Full Text] [Related]
11. [Use of OKT-3 in treatment of rejection following kidney transplantation].
Hansen C; Müller P; Seibt F; Oesterwitz H; May G; Strobelt V; Kaden J; Ditscherlein G; Scholz D
Z Urol Nephrol; 1990 Apr; 83(4):165-70. PubMed ID: 2116055
[TBL] [Abstract][Full Text] [Related]
12. Reversing cardiac transplant rejection with Orthoclone OKT3.
Dault LA; Nagy CS; Collins JA
Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
[No Abstract] [Full Text] [Related]
13. Nursing guidelines for muromonab-CD3 (OKT3).
Duffy MM; Nestor A
ANNA J; 1992 Oct; 19(5):493-5. PubMed ID: 1456797
[TBL] [Abstract][Full Text] [Related]
14. [Orthoclone OKT3 (Muromonab CD3)--the indications for and manner of its use. Side effects and their prevention].
Filev A; Kumanov Kh; Slavov Ch; Tsvetkov M
Khirurgiia (Sofiia); 1989; 42(6):80-2. PubMed ID: 2517512
[TBL] [Abstract][Full Text] [Related]
15. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
16. Orthoclone OKT3 treatment of acute renal allograft rejection.
Friedman J; Barnes L; Sheahan M; Tsai H; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 2):46. PubMed ID: 3105144
[No Abstract] [Full Text] [Related]
17. Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation.
Hooks MA; Wade CS; Millikan WJ
Pharmacotherapy; 1991; 11(1):26-37. PubMed ID: 1902291
[TBL] [Abstract][Full Text] [Related]
18. Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation.
Gordon RD; Tzakis AG; Iwatsuki S; Todo S; Esquivel CO; Marsh JW; Stieber A; Makowka L; Starzl TE
Am J Kidney Dis; 1988 Feb; 11(2):141-4. PubMed ID: 3124609
[TBL] [Abstract][Full Text] [Related]
19. Muromonab CD3. A review of its pharmacology and therapeutic potential.
Todd PA; Brogden RN
Drugs; 1989 Jun; 37(6):871-99. PubMed ID: 2503348
[TBL] [Abstract][Full Text] [Related]
20. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
[Next] [New Search]